Profile
| Metric | Value |
|---|---|
| Full Name | Omada Health, Inc. |
| Ticker | NASDAQ: OMDA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Health Information Services |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | omadahealth.com |
| Employees | 849 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $14.90 | |
| Price, 1D Change | -5.58% | |
| Market Cap | $863M | |
| - | ||
| PE Ratio | - | |
| Beta | 1.13 | |
| Revenue | $170M | |
| Revenue, 1Y Change | +38.29% | |
| EPS | -$0.85 | |
| EPS, 1Y Change | +30.18% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$0.85 | |
| EPS Estimate | -$0.10 | |
| EPS Est. Change | +88.47% | |
| Revenue | $169.80M | |
| Revenue Estimate | $253.37M | |
| Revenue Est. Change | +49.22% | |
| Current Price | $14.90 | |
| Price Target | - | $28.50 |
| Price Tgt. Change | - | +91.28% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.10 | N/A | - | |
| $0.03 | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $253.37M | N/A | - | |
| $310.56M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | - | |
| Price, 3Y | - | |
| Market Cap, 1Y | - | |
| Market Cap, 3Y | - | |
| Revenue, 1Y | +38.29% | |
| Revenue, 3Y | +90.39% | |
| EPS, 1Y | +30.18% | |
| EPS, 3Y | +35.00% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $14.90 | |
| SMA 200 | $20.00 | |
| SMA 200 vs Price | +34.26% | |
| SMA 50 | $19.08 | |
| SMA 50 vs Price | +28.07% | |
| Beta | 1.13 | |
| ATR | $0.90 | |
| 14-Day RSI | 37.23 | |
| 10-Day Volatility | 60.23% | |
| 1-Year Volatility | 68.03% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $169.80M | |
| EPS | -$0.85 | |
| Gross Profit | $102.88M | |
| Gross Margin | 60.59% | |
| Operating Profit | -$43.65M | |
| Operating Margin | -25.71% | |
| Net Income | -$47.14M | |
| Net Margin | -27.76% | |
| EBITDA | -$37.83M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.46 | |
| Current Ratio | 2.10 | |
| Quick Ratio | 2.03 | |
| Interest Coverage | -9.46 | |
| - | ||
| Altman Z-Score | 2.55 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 3.71 | |
| PB Ratio | 3.97 | |
| EV/EBITDA | -39.00 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | -$384.40M | |
| Cash & Equivalents | $76.39M | |
| Total Assets | $150.89M | |
| Current Assets | $113.06M | |
| Total Liabilities | $86.26M | |
| Current Liabilities | $53.95M | |
| Total Debt | $30.19M | |
| Short Term Debt | $415.00K | |
| Accounts Payable | $4.17M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $213.45M | |
| Operating Expenses | $146.53M | |
| Cost Of Goods Sold | $66.92M | |
| SG&A | $110.61M | |
| D&A | $4.80M | |
| Interest Expense | $4.51M | |
| Income Tax | $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | -$34.18M | |
| CFI | -$3.86M | |
| CFF | -$1.21M | |
| Capex | $3.86M | |
| Free Cash Flow | -$38.04M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| BMO Capital | ||
| Needham | → | |
| Evercore ISI Group | → | |
| Barclays | → | |
| Barclays | → | |
| Baird | ||
| Needham | → | |
| Canaccord Genuity | → | |
| Barclays | → | |
| Evercore ISI Group | → |
Analyst sentiment
Institutional ownership
Screeners with OMDA
Data Sources & References
- OMDA Official Website www.omadahealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1611115/000162828025050622/0001628280-25-050622-index.htm
- OMDA Profile on Yahoo Finance finance.yahoo.com/quote/OMDA
- OMDA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/omda
FAQ
What is the ticker symbol for Omada Health, Inc.?
The ticker symbol for Omada Health, Inc. is NASDAQ:OMDA
Does Omada Health, Inc. pay dividends?
No, Omada Health, Inc. does not pay dividends
What sector is Omada Health, Inc. in?
Omada Health, Inc. is in the Healthcare sector
What industry is Omada Health, Inc. in?
Omada Health, Inc. is in the Health Information Services industry
What country is Omada Health, Inc. based in?
Omada Health, Inc. is headquartered in United States
When did Omada Health, Inc. go public?
Omada Health, Inc. initial public offering (IPO) was on June 6, 2025
Is Omada Health, Inc. in the S&P 500?
No, Omada Health, Inc. is not included in the S&P 500 index
Is Omada Health, Inc. in the NASDAQ 100?
No, Omada Health, Inc. is not included in the NASDAQ 100 index
Is Omada Health, Inc. in the Dow Jones?
No, Omada Health, Inc. is not included in the Dow Jones index
When was Omada Health, Inc. last earnings report?
Omada Health, Inc.'s most recent earnings report was on November 6, 2025
When does Omada Health, Inc. report earnings?
The next expected earnings date for Omada Health, Inc. is March 26, 2026